Firm Once Owned By 'Pharma Bro' Shkreli To Pay $40 Million To Settle Price Gouging Lawsuit
A company once owned by "Pharma Bro" Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4,000% after obtaining exclusive rights to the drug.